1.50

Discussion in 'Synergy Pharmaceuticals' started by anonymous, Oct 4, 2018 at 9:14 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest


    You made a poor decision investing in this company. Get lost! Loser!
     

  2. anonymous

    anonymous Guest

    The law firm got payed off. Hope you lost your ass. This company was a house of cards from the start. The product is a me-too, and no worse and no better than the others.
    The entire business plan, if there was one, was built on selling the company or just the product. It was a get rich quick scheme from the get go. You were dumb enough to fall for it...and, sadly, so did we. We just couldn’t get enough lipstick on that pig.
    So STFU and stop your whining. You lost nothing compared to us. You’re just a bad investor.
     
  3. anonymous

    anonymous Guest

    Agree. it was a big nothing burger. Absolutely no illegal activity proved.
     
  4. anonymous

    anonymous Guest

    Upper management, you are the worst. No GI experience then you hired more people with no GI experience. Management you stink
     
  5. anonymous

    anonymous Guest

    Nailed It!
     
  6. anonymous

    anonymous Guest

    Trulance is a me too drug. The coverage sucks too. Company is bankrupt. Move on.
     
  7. anonymous

    anonymous Guest

    Thats like saying all antidepressants that work on serotonin are all "me too drugs." You're either a disgruntled investor who hasn't the slightest idea about GI, or a puppet sample dropping crybaby Allergan rep who has been brainwashed and mislead by the company into believing a drug that exploits the mechanism of travelers' diarrhea is the be all end all of constipation relief.

    Ask any GI who has extensive experience (more than 50 patients) with both medications and they will tell you that a vast majority of their patients are happier and more compliant on Trulance than any Linzess dose. The Linzess 72 microgram data is absolutely pathetic, and the way their reps run around positioning it for "elderly patients who can't tolerate 145mcg" without any sufficient geriatric data, while also avoiding showing the garbage data from the studies, is shameful and illegal.
     
  8. anonymous

    anonymous Guest

    Welcome to the Pharma world. This must be you’re first pharma job. Lying is #1 on the list of skills needed to “ sell” drugs. Are we rally that different? Is our data REALLY any better? Are our studies any more truthful?
    Want to get relief....fiber. Works every time. Cheap, natural, found in all foods. Add some fluid and you’re good to go.
    You’re naive and drink the kool aid....stay that way if you want to survive in the pharma world.
     
  9. anonymous

    anonymous Guest

    Dr. Asshole just cured constipation... no constipation is severe enough for prescription meds, just take fiber.
     
  10. anonymous

    anonymous Guest

    love the comment from management. First they had no GI experience, they had no clue on territory business. Formulary was a foreign word.
    No competitive selling skills. The regionals hired their friends as managers and some came from device.
    If they hired the right regionals and VP’s that knew how to sell a GI drug or at least the marketplace maybe the company would still be here.
     
  11. anonymous

    anonymous Guest

    Unfortunately a knowledge of GI was not the problem in that the majority of the team DOES have GI experience. Instead it was their poor choices in hiring leadership. In particular, not ONE of senior leadership ever did start up. Never did small biotech pharma. They all came from organizations that had layers of personnel and budgets to support it. The leadership team spent money like water on consultants, trips, salaries like they were big pharma. Holding leadership meetings when teleconferences could have sufficed. Extravagant launch and national meeting. People at catalyst that didn’t need to be there. Layers of internal employees in marketing, sales opts that were unnecessary not to mention having two training managers this last year and keeping them on payroll long after we knew there was no backfill or national meetings to plan. How about a director of communication to write a weekly newsletter that no one reads?

    The Marianne sold Troy on the idea of too many managers and reps to launch. Hiring field trainers at high salaries thinking their GI experience would move market share and then not removing those that didn’t make that happen was criminal.

    This was a disaster from the start and no one stopped the level of spending and lack of accountability. Building out a corporate office in Wayne in the first six months of launch? Ridiculous. Shame on leadership. And a shame for all of us who will be jobless within a month.
     
  12. anonymous

    anonymous Guest

    Bravo! Well said and 200% accurate.
    Buffoons way out of their leagues pissed away a great opportunity for many.
    It always astounds me that seemingly intelligent people can be so stupid and have no common sense.
    Many management hires were phonies and frauds... has been or never was’s struggling to be relevant. Pharma is full of them.
    Anyway, good luck to all in your future endeavors. Pharma is a great gig while it lasts, but, for me, it’s time to look elsewhere for a real job with, hopefully, more longevity/security. Good luck to me finding it.
     
  13. anonymous

    anonymous Guest

    .09. Not worth the paper it’s printed on. A total failure that should have been the opposite.
    Well, coulda, woulda, shoulda ain’t gonna feed the family, and out I go to find another
    job.....OUT OF PHARMA.